Pulmonary obstructions are a serious complication of lung cancer and metastasis of many other types of cancers.

Breast

· Prostate

· Lung

· Colorectal

· Melanoma & Skin

· Bladder

· Pancreatic

· Uterine Corpus

· Kidney and Renal Pelvis

· Non-Hodgkin Lymphoma

· Breast · Prostate · Lung · Colorectal · Melanoma & Skin · Bladder · Pancreatic · Uterine Corpus · Kidney and Renal Pelvis · Non-Hodgkin Lymphoma ·

ESTIMATED PATIENTS WITH PULMONARY OBSTRUCTIONS ANNUALLY

372,200

We exist to help cancer patients breathe easier.

The AMStent® System

Minimizing foreign body response by leveraging human amnion-derived biomaterial

AMSTENT OUTCOMES

AMStent outcomes show significantly less inflammation

AMStent System outcome fully bio-incorporated, restored ciliated epithelium

Pre-clinical outcomes¹ show the AMStent System is associated with significantly less mucus accumulation, stent migration, inflammation, and granuloma formation than a commercially available control stent - outcomes that matter for patients with pulmonary obstructions.

See how AMStent works

¹ On file, Peytant Solutions Chronic GLP Animal Study